表紙
市場調查報告書
商品編碼
232774

第二型糖尿病:開發中產品分析

Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021

出版日期: | 出版商: Global Markets Direct | 英文 1416 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

第二型糖尿病是慢性疾病,也是最常見的糖尿病。特徵是血糖值高,身體抗拒胰島素,而漸漸無法產生足夠的胰島素。胰島素功能異常會造成葡萄糖濃縮,血糖值提升,而引起第二型糖尿病。症候有疲勞感,體重減輕,視力模糊等的各種影響。風險要素有家族病史,肥胖,身體不活動和高血壓。可用改變生活方式及定期性的藥物治療等來控制處理。

本報告提供第二型糖尿病的治療藥開發平台現狀及最新更新的各開發階段比較分析,提供您夾雜了最新的新聞和發表之企業和研究機關開發中治療藥,治療藥評估,後期階段及中止的計劃等相關資訊。。

簡介

第二型糖尿病概要

治療藥的開發

第二型糖尿病:治療藥的評估

第二型糖尿病的治療藥開發企業

藥物簡介

暫停中的計劃

開發中止的產品

產品開發的里程碑

附錄

表格

目錄
Product Code: GMDHC13118IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing type 2 diabetes. Symptoms include fatigue, weight issues, vision deficits and various other effects. Risk factors include family history, age, obesity, physical inactivity and high blood pressure. This condition is handled by lifestyle alterations and regular medications.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Type 2 Diabetes (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 16, 1, 54, 74, 87, 3, 23, 254, 50 and 11 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 59 and 16 molecules, respectively.

Type 2 Diabetes (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Type 2 Diabetes (Metabolic Disorders).
  • The pipeline guide reviews pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Type 2 Diabetes (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Type 2 Diabetes (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders)

Reasons to Buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Type 2 Diabetes (Metabolic Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Type 2 Diabetes (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents

  • Introduction
  • Type 2 Diabetes - Overview
  • Type 2 Diabetes - Therapeutics Development
  • Type 2 Diabetes - Therapeutics Assessment
  • Type 2 Diabetes - Companies Involved in Therapeutics Development
  • Type 2 Diabetes - Drug Profiles
  • Type 2 Diabetes - Dormant Projects
  • Type 2 Diabetes - Discontinued Products
  • Type 2 Diabetes - Product Development Milestones
  • Appendix

List of Tables

List of Tables

  • Number of Products under Development for Type 2 Diabetes, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Type 2 Diabetes - Pipeline by 3SBio Inc, 2021
  • Type 2 Diabetes - Pipeline by Abarceo Pharma AB, 2021
  • Type 2 Diabetes - Pipeline by Adare Pharma Solutions, 2021
  • Type 2 Diabetes - Pipeline by Addpharma Inc, 2021
  • Type 2 Diabetes - Pipeline by ADM Therapeutics, 2021
  • Type 2 Diabetes - Pipeline by Adocia SAS, 2021
  • Type 2 Diabetes - Pipeline by Aerami Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Afimmune Biopharma Ltd, 2021
  • Type 2 Diabetes - Pipeline by Agentix Corp, 2021
  • Type 2 Diabetes - Pipeline by AgeX Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Aju Pharm Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Akero Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Akston Biosciences Corp, 2021
  • Type 2 Diabetes - Pipeline by Algiax Pharmaceuticals GmbH, 2021
  • Type 2 Diabetes - Pipeline by Alms Therapeutics, 2021
  • Type 2 Diabetes - Pipeline by Alnylam Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by AlphaMab Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Altimmune Inc, 2021
  • Type 2 Diabetes - Pipeline by AltrixBio Inc, 2021
  • Type 2 Diabetes - Pipeline by Amide Technologies Inc, 2021
  • Type 2 Diabetes - Pipeline by AmideBio LLC, 2021
  • Type 2 Diabetes - Pipeline by Anagenesis Biotechnologies SAS, 2021
  • Type 2 Diabetes - Pipeline by Ananda Scientific Inc, 2021
  • Type 2 Diabetes - Pipeline by Anji Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by AnyGen Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Apcegen Technologies Pvt Ltd, 2021
  • Type 2 Diabetes - Pipeline by Aphios Corp, 2021
  • Type 2 Diabetes - Pipeline by Apoglyx AB, 2021
  • Type 2 Diabetes - Pipeline by Dong-A ST Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by EastGate Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by Eccogene (Shanghai) Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Egy-Nano Pharma LP, 2021
  • Type 2 Diabetes - Pipeline by Elevian Inc, 2021
  • Type 2 Diabetes - Pipeline by Eli Lilly and Co, 2021
  • Type 2 Diabetes - Pipeline by Emerald Organic Products Inc, 2021
  • Type 2 Diabetes - Pipeline by Emmaus Life Sciences Inc, 2021
  • Type 2 Diabetes - Pipeline by Empros Pharma AB, 2021
  • Type 2 Diabetes - Pipeline by EncuraGen Inc, 2021
  • Type 2 Diabetes - Pipeline by Energenesis Biomedical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Enesi Pharma Ltd, 2021
  • Type 2 Diabetes - Pipeline by Enteris BioPharma Inc, 2021
  • Type 2 Diabetes - Pipeline by Enzene Biosciences Ltd, 2021
  • Type 2 Diabetes - Pipeline by Enzo Biochem Inc, 2021
  • Type 2 Diabetes - Pipeline by Epichem Pty Ltd, 2021
  • Type 2 Diabetes - Pipeline by Eternygen GmbH, 2021
  • Type 2 Diabetes - Pipeline by Evotec SE, 2021
  • Type 2 Diabetes - Pipeline by F. Hoffmann-La Roche Ltd, 2021
  • Type 2 Diabetes - Pipeline by Fairbanks Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by Fochon Pharmaceutical Ltd, 2021
  • Type 2 Diabetes - Pipeline by Forkhead BioTherapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by FortuneRock (China) Ltd, 2021
  • Type 2 Diabetes - Pipeline by Fujian Haixi New Medicine Creation Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Gan & Lee Pharmaceuticals Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Generex Biotechnology Corp, 2021
  • Type 2 Diabetes - Pipeline by Genexine Inc, 2021
  • Type 2 Diabetes - Pipeline by Genovate Biotechnology Co LTD, 2021
  • Type 2 Diabetes - Pipeline by Genprex Inc, 2021
  • Type 2 Diabetes - Pipeline by Geropharm, 2021
  • Type 2 Diabetes - Pipeline by GL Pharm Tech Corp, 2021
  • Type 2 Diabetes - Pipeline by Glaceum Inc, 2021
  • Type 2 Diabetes - Pipeline by Glucox Biotech AB, 2021
  • Type 2 Diabetes - Pipeline by Glyscend Inc, 2021
  • Type 2 Diabetes - Pipeline by Gmax Biopharm LLC, 2021
  • Type 2 Diabetes - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Gubra ApS, 2021
  • Type 2 Diabetes - Pipeline by Gusto Global LLC, 2021
  • Type 2 Diabetes - Pipeline by Hangzhou East China Pharmaceutical Group Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Hangzhou Jiuyuan Gene Engineering Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by HCW Biologics Inc, 2021
  • Type 2 Diabetes - Pipeline by HEC Pharma Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Hefei Industrial Pharmaceutical Institute Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Hengrui Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by HighTide Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by HK inno.N Corp, 2021
  • Type 2 Diabetes - Pipeline by Housey Pharmaceutical Research Laboratories LLC, 2021
  • Type 2 Diabetes - Pipeline by Hua Medicine Shanghai Ltd, 2021
  • Type 2 Diabetes - Pipeline by Huadong Medicine Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Hualan Biological Engineering Inc, 2021
  • Type 2 Diabetes - Pipeline by Hyundai Pharma Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Ildong Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Imagine Pharma LLC, 2021
  • Type 2 Diabetes - Pipeline by Immunwork Inc, 2021
  • Type 2 Diabetes - Pipeline by Immupharma Plc, 2021
  • Type 2 Diabetes - Pipeline by Immuron Ltd, 2021
  • Type 2 Diabetes - Pipeline by Impetis Biosciences Ltd, 2021
  • Type 2 Diabetes - Pipeline by Inflammasome Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Innovimmune Biotherapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Inspyr Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Intarcia Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Integral Molecular Inc, 2021
  • Type 2 Diabetes - Pipeline by Ionis Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by Japan Tobacco Inc, 2021
  • Type 2 Diabetes - Pipeline by Jeil Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Jiangsu Lianhuan Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Jiangsu T-mab BioPharma Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Johnson & Johnson, 2021
  • Type 2 Diabetes - Pipeline by Kadimastem Ltd, 2021
  • Type 2 Diabetes - Pipeline by Kaneq Bioscience Ltd, 2021
  • Type 2 Diabetes - Pipeline by Karyo Biologics LLC, 2021
  • Type 2 Diabetes - Pipeline by KB Biomed Inc, 2021
  • Type 2 Diabetes - Pipeline by Klotho Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Kolmar Korea Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Kriya Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Kyung Dong Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Laboratorios Silanes SA de CV, 2021
  • Type 2 Diabetes - Pipeline by Lannett Co Inc, 2021
  • Type 2 Diabetes - Pipeline by Lanzhou Institute of Biological Products Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Lead Discovery Center GmbH, 2021
  • Type 2 Diabetes - Pipeline by Lepu Medical Technology (Beijing) Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Levim Biotech LLP, 2021
  • Type 2 Diabetes - Pipeline by Lexicon Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by LG Chem Ltd, 2021
  • Type 2 Diabetes - Pipeline by Oncosimis Biotech Pvt Ltd, 2021
  • Type 2 Diabetes - Pipeline by OPKO Health Inc, 2021
  • Type 2 Diabetes - Pipeline by OptiKira LLC, 2021
  • Type 2 Diabetes - Pipeline by Oramed Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by Orbsen Therapeutics Ltd, 2021
  • Type 2 Diabetes - Pipeline by Original BioMedicals Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Palatin Technologies Inc, 2021
  • Type 2 Diabetes - Pipeline by Palisade Bio, Inc, 2021
  • Type 2 Diabetes - Pipeline by Panorama Researchama Research, 2021
  • Type 2 Diabetes - Pipeline by Paras Biopharmaceuticals Finland Oy, 2021
  • Type 2 Diabetes - Pipeline by Park Active Molecules, 2021
  • Type 2 Diabetes - Pipeline by PegBio Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Peptron Inc, 2021
  • Type 2 Diabetes - Pipeline by Pfizer Inc, 2021
  • Type 2 Diabetes - Pipeline by PharmaCyte Biotech Inc, 2021
  • Type 2 Diabetes - Pipeline by Pila Pharma AB, 2021
  • Type 2 Diabetes - Pipeline by Polus Inc, 2021
  • Type 2 Diabetes - Pipeline by Poxel SA, 2021
  • Type 2 Diabetes - Pipeline by Preveceutical Medical Inc, 2021
  • Type 2 Diabetes - Pipeline by ProLynx LLC, 2021
  • Type 2 Diabetes - Pipeline by Prometheon Pharma LLC, 2021
  • Type 2 Diabetes - Pipeline by Protheragen Inc, 2021
  • Type 2 Diabetes - Pipeline by Prous Institute for Biomedical Research SA, 2021
  • Type 2 Diabetes - Pipeline by Purzer Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Qoracle Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by QuiaPEG Pharmaceuticals AB, 2021
  • Type 2 Diabetes - Pipeline by Rani Therapeutics LLC, 2021
  • Type 2 Diabetes - Pipeline by Rebio Technologies Ltd, 2021
  • Type 2 Diabetes - Pipeline by Regenerative Medical Solutions Inc, 2021
  • Type 2 Diabetes - Pipeline by Remd Biotherapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Remedium Bio Inc, 2021
  • Type 2 Diabetes - Pipeline by reMYND NV, 2021
  • Type 2 Diabetes - Pipeline by Renova Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Retinset SL, 2021
  • Type 2 Diabetes - Pipeline by Rezolute Inc, 2021
  • Type 2 Diabetes - Pipeline by Ridgeline Therapeutics LLC, 2021
  • Type 2 Diabetes - Pipeline by Rivus Pharmaceuticals Inc, 2021
  • Type 2 Diabetes - Pipeline by RosVivo Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Samik Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Samjin Pharm Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sanofi, 2021
  • Type 2 Diabetes - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by SBI Pharmaceuticals Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by ScandiCure AB, 2021
  • Type 2 Diabetes - Pipeline by Sciwind Biosciences Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Scohia Pharma Inc, 2021
  • Type 2 Diabetes - Pipeline by Senseion Inc, 2021
  • Type 2 Diabetes - Pipeline by Sensulin LLC, 2021
  • Type 2 Diabetes - Pipeline by Seres Therapeutics Inc, 2021
  • Type 2 Diabetes - Pipeline by Serodus ASA, 2021
  • Type 2 Diabetes - Pipeline by Serpin Pharma LLC, 2021
  • Type 2 Diabetes - Pipeline by Shaanxi Micot Technology Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shandong Baijidichang Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shandong Luye Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shanghai Fosun Pharmaceutical (Group) Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shanghai HEP Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shanghai Innogen Pharmaceutical Technology Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shanghai Yingli Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shenzhen Salubris Pharmaceuticals Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shionogi & Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Shouyao Holding Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sichuan Haisco Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sihuan Pharmaceutical Holdings Group Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sino Biopharmaceutical Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sirona Biochem Corp, 2021
  • Type 2 Diabetes - Pipeline by SJT Molecular Research SL, 2021
  • Type 2 Diabetes - Pipeline by SK Chemicals Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sosei Group Corp, 2021
  • Type 2 Diabetes - Pipeline by Stelis Biopharma Pvt Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sulfateq BV, 2021
  • Type 2 Diabetes - Pipeline by Sun Pharmaceutical Industries Ltd, 2021
  • Type 2 Diabetes - Pipeline by Sveikatal Inc, 2021
  • Type 2 Diabetes - Pipeline by SymbioCellTech LLC, 2021
  • Type 2 Diabetes - Pipeline by Synokem Pharmaceuticals Ltd, 2021
  • Type 2 Diabetes - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Techfields Pharma Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by The Healthy Aging Co, 2021
  • Type 2 Diabetes - Pipeline by The United Laboratories International Holdings Ltd, 2021
  • Type 2 Diabetes - Pipeline by Theracos Inc, 2021
  • Type 2 Diabetes - Pipeline by Thermalin Inc, 2021
  • Type 2 Diabetes - Pipeline by Tonghua Dongbao Pharmaceutical Co Ltd, 2021
  • Type 2 Diabetes - Pipeline by Torrent Pharmaceuticals Ltd, 2021
  • Type 2 Diabetes - Dormant Projects, 2021
  • Type 2 Diabetes - Discontinued Products, 2021

List of Figures

List of Figures

  • Number of Products under Development for Type 2 Diabetes, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021